title: 13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.
authors.affiliation: Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
authors.forename: S M
authors.initials: SM
authors.lastname: Lippman
authors.forename: J J
authors.initials: JJ
authors.lastname: Kavanagh
authors.forename: M
authors.initials: M
authors.lastname: Paredes-Espinoza
authors.forename: F
authors.initials: F
authors.lastname: Delgadillo-Madrueño
authors.forename: P
authors.initials: P
authors.lastname: Paredes-Casillas
authors.forename: W K
authors.initials: WK
authors.lastname: Hong
authors.forename: G
authors.initials: G
authors.lastname: Massimini
authors.forename: E E
authors.initials: EE
authors.lastname: Holdener
authors.forename: I H
authors.initials: IH
authors.lastname: Krakoff
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D015474:Isotretinoin / Q000008:administration & dosage; D008875:Middle Aged; D011994:Recombinant Proteins; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D015474:Isotretinoin